← Back to blog

Andy vs. Limeai: AI Scribe for Home Health (November 2026)

Compare Andy and Limeai on home health scribing, QA, coding, and EMR depth to find the stronger fit for your agency. November 2026.

Tiantian Zha
Tiantian ZhaCo-founder, Andy
PublishedNovember 13, 2026
UpdatedNovember 13, 2026

Choosing between Andy and Limeai isn't really about which one records a visit better. It's about what happens after the visit: how complete the chart is, whether coding runs the same day, and whether your clinical team is reviewing a finished draft or rebuilding one. That's where these two tools go in very different directions.

TLDR:

What Is Lime ai?

Lime Health AI, founded in 2025, built Lime Scribe as an ambient clinical scribe for home health and hospice. It listens during patient encounters and generates OASIS, HOPE, and daily visit notes in real time.

What Is Andy?

Andy is a mobile app built for home health nurses that combines ambient scribing, QA, and ICD-10 coding in one place. Charts are AI-generated and human-reviewed by clinical experts, cutting a 90-minute documentation process down to a 15-minute review, and delivered straight into your existing EMR. Andy has worked with home health agencies since 2023, so its customers have already taken Andy-documented charts through state surveys and know the accuracy is something they can rely on.

Ambient Scribing Capabilities

Both tools listen during a visit and generate notes from audio. The difference is in how deep that output goes for home health.

Lime Scribe covers OASIS, HOPE, and daily visit notes, a range worth reviewing in any home health AI scribe comparison. The product is new, with the company founded in 2025, so its output has had little time in front of surveyors.

Andy's ambient scribing for home health has been built and refined with home health agencies since 2023. Two taps to start, then the nurse does the visit. By the time they leave the driveway, Andy has drafted the full chart: assessment, narrative, wounds, meds, and OASIS. Home health documentation has its own complexity, and the model is trained on years of real home health documentation.

The output depth matters for OASIS in particular. A generic visit note is one thing; an accurate and compliant OASIS chart that holds up to scrutiny is another. Because Andy-documented OASIS charts have been going through real surveys since 2023, agencies know the clinical specificity in every draft holds up.

QA and Coding Depth

Lime Scribe does offer QA and coding alongside its scribing features, and that range of coverage is worth noting. Building a scribe, QA engine, ICD-10 coding workflow, and a new EMR concurrently is a wide surface area for a company founded in 2025 with under 50 employees.

Andy's QA and coding are built directly around home health compliance. Our home health QA reads the full history and physical, flags inconsistencies, keeps medication lists clean, and helps clinicians document survey-ready on the first pass. Home health coding runs in the same app, with clinician confirmation built in, so episodes bill in a day instead of sitting in a backlog for weeks.

That speed has real financial impact. When coding is accurate and documentation is complete, claims move. Agencies using Andy see faster billing submission and fewer rework cycles, which matters when margins are already tight.

The distinction here is track record. Lime Health AI is building a scribe, QA, coding, and its own EMR all within its first couple of years. Andy has refined home health QA and coding since 2023, with clinical oversight in every step and agencies that have gone through surveys on documentation Andy helped produce.

EMR Integration and Workflow Fit

Lime Scribe lists integrations with several major EMRs including MatrixCare, Homecare Homebase, Netsmart, WellSky, and Axxess. For agencies on those systems, that list is a reasonable starting point.

The trade-off worth considering is depth versus count. Supporting a wide range of EMRs simultaneously, especially for a company founded in 2025, often means those connections are lighter touch. Shallower write-back creates friction at exactly the wrong moment: when a nurse is trying to close a chart and move to the next visit.

Andy integrates deeply with the EMRs our agency partners already run, including WellSky and Axxess (see Andy AI for your home health EMR). Charts flow directly into the EMR without extra manual steps, which is where compliance and billing speed live. A completed chart that requires manual re-entry, or sits outside the EMR waiting for someone to transfer it, slows down your revenue cycle and introduces error risk. That friction is exactly what good OASIS documentation practices are designed to prevent. Integration depth is what determines whether documentation actually lands clean on the first pass.

Human Review and Clinical Oversight

Both tools include some form of human review, and the question for home health clinical leaders is what that review actually catches and who's doing it.

Andy's review layer is built around clinical experts who understand home health skilled nursing compliance, going well beyond documentation formatting. Every chart goes through review before it lands in the EMR, which means inconsistencies, missing clinical justification, and OASIS inaccuracies get caught before they become a survey finding or a denied claim. That distinction matters when your agency's reimbursement depends on documentation that holds up.

Survey readiness is where clinical oversight earns its cost. A chart that looks complete but contains conflicting entries or unsupported coding is a liability. Andy's QA and human review work together so clinicians document correctly on the first pass, reducing rework and protecting the agency during audits. Andy has worked with home health agencies since 2023, so its customers have already been through surveys with Andy-documented charts. A tool launched in 2025 has had little time to show that same track record. For a deeper look at home health compliance and audit readiness, CMS requirements and OASIS best practices are worth reviewing.

AndyLimeai (Lime Scribe)
Ambient scribingHome health-specific model; full chart drafted before nurse leaves drivewayCovers OASIS, HOPE, and daily visit notes across multiple settings
QABuilt for home health compliance; flags inconsistencies and supports survey-ready documentationIncluded, but spread across multiple post-acute settings
ICD-10 codingIn-app with clinician confirmation; episodes bill in a dayOffered alongside scribe; depth may vary given multi-setting focus
EMR integrationDeep write-back; charts land clean on the first passIntegrates with MatrixCare, HCHB, Netsmart, WellSky, Axxess; depth varies
Human reviewEvery chart reviewed by clinical experts before reaching EMRSome form of review included
Documentation time90-minute process cut to a 15-minute reviewNot specified
Best fitHome health agencies focused on depth, compliance, and billing speedMulti-setting post-acute organizations wanting one vendor

Why Andy Is the Better Choice for Home Health Agencies

Lime Scribe may suit agencies that want a single vendor spanning home health, hospice, and skilled nursing, especially if broad EMR coverage across care settings is a priority. For agencies focused squarely on home health, that breadth is less of an advantage and more of a trade-off.

The results are concrete: 2x nurse productivity, up to 45% more detailed charts (Andy internal agency data), and episodes that bill in a day instead of sitting in a backlog for weeks. If home health documentation depth, compliance, and revenue cycle speed are your priorities, Andy is the stronger fit.

Final Thoughts on How Andy and Limeai Compare for Home Health

Both tools solve real problems, but they solve different ones. If your agency runs home health, the specificity of a purpose-built tool shows up in your charts and your bottom line. That focus is worth weighing carefully before you decide.

FAQ

How should home health agency directors decide between Andy and Limeai?

The decision comes down to what your agency needs most from a documentation partner. If survey-tested accuracy, deep EMR integration, and billing speed are your priorities, Andy is the stronger fit: it has worked with home health agencies since 2023, and its customers have already taken Andy-documented charts through surveys. Limeai, founded in 2025, may be worth considering if a long list of supported EMRs matters more to you than integration depth.

What is the core difference between how Andy and Limeai handle QA and coding for home health?

Andy's QA and ICD-10 coding are built for home health compliance and have been refined with agencies since 2023, with clinical experts reviewing every chart before it reaches your EMR so episodes bill in a day instead of sitting in a backlog for weeks. Limeai offers QA and coding alongside its scribe, but as a company founded in 2025 that is also building its own EMR, those workflows have had far less time in the field.

Who is Andy built for, and what types of agencies is Limeai better suited to?

Andy is built for home health agencies where field nurses are managing complex documentation, OASIS accuracy, and tight revenue cycle timelines, and where leaders need documentation that has already held up through surveys. Limeai may be a better fit for agencies that put the widest possible list of EMR integrations ahead of integration depth and track record.

Can Andy integrate with the EMR my agency already runs?

Andy integrates directly with the EMRs home health agencies already use, with charts flowing into the EMR without extra manual steps or re-entry. Shallow write-back connections introduce error risk and slow down your revenue cycle, so Andy's approach to integration depth is what allows documentation to land clean on the first pass.

What should clinical directors know about the human review process in Andy versus Limeai?

Andy's review layer is staffed by clinical experts who understand home health compliance. Every chart is reviewed before it reaches the EMR, catching inconsistencies, missing clinical justification, and OASIS inaccuracies before they become a survey finding or a denied claim. Both tools include some form of review, but the depth and clinical specificity of that oversight is what determines whether your agency stays protected during audits.